Skip to main content
Walter Kaufmann, MD, Cardiology, Port Jervis, NY

WalterErnstKaufmannMD

Cardiology Port Jervis, NY

Adult Congenital Heart Disease, Cardiac Electrophysiology

Physician

Are you Dr. Kaufmann?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 56 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    161 E Main St
    Community Medical Care
    Port Jervis, NY 12771
    Phone+1 845-858-2666
    Fax+1 845-858-2662

Summary

  • Dr. Walter Kaufmann, MD is a cardiologist in Port Jervis, New York. He is currently licensed to practice medicine in New York and New Jersey. He is affiliated with Bon Secours Community Hospital.

Education & Training

  • Rutgers Health/Newark Beth Israel Medical Center
    Rutgers Health/Newark Beth Israel Medical CenterFellowship, Cardiovascular Disease, 1980 - 1982
  • Rutgers Health/New Jersey Medical School
    Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 1977 - 1980
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 1977

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License Current
  • NY State Medical License
    NY State Medical License 1982 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
  • Fellow (FACC) American College of Cardiology

Press Mentions

  • Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (Blarcamesine) in Rett Syndrome
    Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 (Blarcamesine) in Rett SyndromeNovember 6th, 2019
  • Anavex Life Sciences Presented at the 6th Annual European Rett Syndrome Conference Preliminary Clinical Efficacy Data from the U.S. Rett Syndrome Phase 2 ANAVEX®2-73 Study
    Anavex Life Sciences Presented at the 6th Annual European Rett Syndrome Conference Preliminary Clinical Efficacy Data from the U.S. Rett Syndrome Phase 2 ANAVEX®2-73 StudySeptember 27th, 2019
  • Anavex Life Sciences Reports Fiscal 2019 First Quarter Financial Results and Provides Clinical Study Updates
    Anavex Life Sciences Reports Fiscal 2019 First Quarter Financial Results and Provides Clinical Study UpdatesMarch 28th, 2019

Professional Memberships